The Quigley Corporation Announces Launch of BEVERLY SASSOON Product Line by Its InnerLight Subsidiary.DOYLESTOWN, Pa. -- The Quigley Corporation (Nasdaq: QGLY) today announced that InnerLight, Inc., a wholly-owned subsidiary within the company's Health and Wellness Segment, has secured Beverly Sassoon as a spokesperson and launched an exclusive skin care line under the BEVERLY SASSOON brand name. The BEVERLY SASSOON skin care line has been created and endorsed by Marta Rendon, M.D., President-Elect of the American Academy of Dermatology The American Academy of Dermatology (AAD) is the largest organization of dermatologists in the world. The Academy grants Fellowships and Associate Memberships, as well as Fellowships for Nonresidents (of the United States of America or Canada). as well as Michael F. McGuire, M.D., F.A.C.S., a board certified board certified, adj the status of a dental specialist such as an orthodontist who has become a board diplomate by successfully completing the certification program of the recognized certification board in that area of practice. faculty member at the UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. in Los Angeles Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850. . Stephanie McAnaly, President of InnerLight, said, "Beverly Sassoon's decades of experience in beauty care products, as well as her celebrity status, are a perfect fit for these revolutionary tested skin-care products. InnerLight is thrilled to market the BEVERLY SASSOON skin care brand." The BEVERLY SASSOON exclusive skin care products are all tested by the Doctors who developed them. The line of products is available in the BEVERLY SASSOON Dermaplex Therapie kit. The kit includes the DermaPeel complex facial peel system, as well as OxyPlex, a soothing agent shown in testing to reduce the recovery time from skin treatments. Together, these doctor-developed cosmeceuticals provide a safe, at home, skin-care system that can provide the same results as costly treatments. Also available in the kit is the BEVERLY SASSOON Day Creme and 24-7 pHydration Night Cream, with patented Rendon Rx Complex. Each of the BEVERLY SASSOON products available in the kit can also be purchased separately. The Quigley Corporation (Nasdaq: QGLY, http://www.Quigleyco.com) is a leading developer and marketer of diversified health products including the COLD-EEZE(R) family of patented zinc gluconate glycine glycine (glī`sēn), organic compound, one of the 20 amino acids commonly found in animal proteins. Glycine is the only one of these amino acids that is not optically active, i.e. (ZIGG(TM)) lozenges and sugar free tablets. In September of 2004, The Company has also formed a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. , Quigley Manufacturing, Inc. with the acquisition of two FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved facilities to manufacture its COLD-EEZE(R) branded lozenges. InnerLight, Inc., a wholly owned subsidiary, was formed in January 2001 for the purpose of introducing new products to the marketplace through a network of independent distributors. In addition to Over-The-Counter (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) products, the Company has formed Quigley Pharma Inc. (http://www.QuigleyPharma.com), a wholly owned ethical pharmaceutical subsidiary, to introduce a line of naturally derived patented prescription drugs. The Quigley Corporation's customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion